Biotech Most Volatile: Marina Biotech (OTCMKTS:MRNA), Onconova Therapeutics (NASDAQ:ONTX), OXiGENE Inc (NASDAQ:OXGN), Oragenics Inc (NYSEMKT:OGEN)

Marina Biotech, Inc. (OTCMKTS:MRNA) illustrated a similar run of events, as it reinvigorated its PR activity in the new year and shot upwards as it received a patent protection for one of its therapies. MRNA is back at $1.38, after it slumped for a while following a temporary peak at $1.70. Marina Biotech, Inc. (OTCMKTS:MRNA) stock performance was 16.67% in last session and finished the … Continue reading Biotech Most Volatile: Marina Biotech (OTCMKTS:MRNA), Onconova Therapeutics (NASDAQ:ONTX), OXiGENE Inc (NASDAQ:OXGN), Oragenics Inc (NYSEMKT:OGEN)

Moving Stocks: Huntington Bancshares Incorporated (NASDAQ:HBAN), Advanced Micro Devices (NYSE:AMD), Oragenics Inc. (NYSEMKT:OGEN), CIM Commercial Trust Corporation (NASDAQ:CMCT), Guaranty Bancorp (NASDAQ:GBNK)

Huntington Bancshares (NASDAQ:HBAN)‘s stock had its “neutral” rating reiterated by Zacks in a research note issued on Thursday. They currently have a $10.00 price target on the stock.Zacks‘s price target points to a potential upside of 4.60% from the company’s current price. Huntington Bancshares Incorporated (NASDAQ:HBAN) belongs to Financial sector. Its net profit margin is 32.60% and weekly performance is -1.96%. On last trading day … Continue reading Moving Stocks: Huntington Bancshares Incorporated (NASDAQ:HBAN), Advanced Micro Devices (NYSE:AMD), Oragenics Inc. (NYSEMKT:OGEN), CIM Commercial Trust Corporation (NASDAQ:CMCT), Guaranty Bancorp (NASDAQ:GBNK)

On May 30, 2014 Oragenics Inc (NYSEMKT:OGEN) held its Annual meeting of Shareholders (the “Meeting”), at which Meeting, the Company’s shareholders authorized the amendment to our Amended and Restated Articles of Incorporation (the “Amendment”) to increase the number of authorized common stock to 100,000,000 shares, upon a determination by our Board of Directors that such an increase is in the best interests of our Company … Continue reading Biotech Bullish stocks: Oragenics (NYSEMKT:OGEN), Kindred Biosciences (NASDAQ:KIN), Revance Therapeutics (NASDAQ:RVNC), Stemline Therapeutics (NASDAQ:STML), Aastrom Biosciences (NASDAQ:ASTM)